Actively Recruiting
Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension
Led by University of Giessen · Updated on 2025-04-03
150
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
U
University of Giessen
Lead Sponsor
E
Edwards Lifesciences
Collaborating Sponsor
AI-Summary
What this Trial Is About
In order to reduce the incidence of IOH, various goal-directed therapy (GDT) protocols have already been introduced with success regarding the reduction of postoperative AKI and MINS. However, these studies used an invasive hemodynamic monitoring which offered a continuous surveillance of the blood pressure. In contrast, standard non-invasive blood pressure monitoring results in a blind gap between two measurements (mostly three or five minutes). In order to address this limitation, different continuous non-invasive blood pressure monitoring devices have been introduced. The next evolutional step of non-invasive cardiac output monitoring was to prevent IOH before their onset by using the Hypotension Prediction Index (HPI). Based on the Edward ́s monitoring platform, HPI is a monitoring tool which aims to predict IOH (defined as MAP\<65 mmHg for at least one minute) up to 15 min before its onset. The underlying machine learning based algorithm uses analyses features from the pressure waveform and was first calculated from a large retrospective data set of surgical patients and subsequently validated in a prospective cohort. In this study HPI showed a sensitivity of 88% and specificity of 87% for predicting IOH 15 min before its onset. Since then, own and studies of other working groups confirmed the effective prevention of IOH by the use of HPI-based GDT. Until today the arterial waveform analysis was dependent on invasive arterial measurement but since Edwards Lifesciences already promoted the start of the HPI on the ClearSight platform a non-invasive measurement will soon be possible. Further, until now it has not yet been proven that the perioperative use of a continuous non-invasive blood pressure monitoring has a beneficial effect on the patient´s outcome. Study objectives The aim of the study is to investigate whether a hemodynamic protocol based on continuous non-invasive cardiac output monitoring (ClearSight system) compared to standard care can reduce the incidence of IOH, postoperative AKI, and MINS in patients undergoing major trauma and orthopedic surgery.
CONDITIONS
Official Title
Non-invasive Measurement of the Hypotension Prediction Index for the Reduction of Intraoperative Hypotension
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients undergoing major trauma or orthopedic surgery in supine position which includes reconstructive pelvic surgery, total hip arthroplasty, proximal femur surgery, total knee arthroplasty, or spine surgery
- Planned general anesthesia with duration longer than 90 minutes
- Age 45 years or older
You will not qualify if you...
- Planned invasive blood pressure monitoring
- Participation in another interventional study
- Pregnancy or nursing
- Surgery without controlled mechanical ventilation
- ASA physical status I or IV
- Arterial fibrillation
- Allergy to gelatine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Justus-Liebig-University of Giessen
Giessen, Germany, 35392
Actively Recruiting
Research Team
E
Emmanuel Schneck, M.D.
CONTACT
M
Michael Sander, Prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here